Business Context and Reporting Period
Company: Perpetuals.com Ltd (NASDAQ: PDC)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of April 2026
Date of Filing: April 22, 2026
Principal Executive Office: Tokyo, Japan
The filing serves to disseminate a press release regarding a strategic expansion of the Company's proprietary technology.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or quantitative performance data.
Material Changes
Strategic Expansion: The Company announced the extension of its proprietary "BayesShield AI" technology into the healthcare sector. This initiative aims to address the root cause of diagnostic errors.
Guidance, Outlook, and Risks
Management Commentary: The press release highlights the application of AI technology to solve critical issues in healthcare diagnostics. No specific financial guidance, revenue projections, or risk factors were detailed in this specific filing text.
Investor Verification Checklist
- Verify the technical capabilities and validation status of the BayesShield AI technology in healthcare settings.
- Review the attached Exhibit 99.1 for details on the scope of the healthcare expansion.
- Monitor future filings for financial impact or revenue recognition related to this new sector entry.
- Confirm regulatory requirements for AI deployment in the healthcare industry in relevant jurisdictions.